Published online before print November 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.651117
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:2508-2516.)
© 2006 American Heart Association, Inc.
Vascular Medicine |
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
From the Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee, UK.
Correspondence to A.D. Struthers, MD, FRCP, FESC, Division of Medicine and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. E-mail a.d.struthers{at}dundee.ac.uk
Received July 24, 2006; revision received September 26, 2006; accepted September 28, 2006.
Background— Allopurinol has been shown to improve endothelial function in chronic heart failure. This study aimed to establish its mechanism of action and to construct a dose–response curve for the effect of allopurinol.
Methods and Results— Two randomized, placebo-controlled, double-blind, crossover studies were performed for 1 month on patients with New York Heart Association Class II–III chronic heart failure, comparing 300 mg allopurinol, 600 mg allopurinol, and placebo for the first study and 1000 mg probenecid versus placebo in the second study. Endothelial function was assessed by standard forearm venous occlusion plethysmography. Allopurinol 600 mg/d significantly increased forearm blood flow response to acetylcholine compared with both allopurinol 300 mg/d and placebo (% change in forearm blood flow [mean±SEM]: 240.31±38.19% versus 152.10±18.21% versus 73.96±10.29%, P<0.001). For similar levels of urate lowering, the uricosuric agent probenecid had no effect on endothelial function. Sodium nitroprusside response was unchanged by all treatments. Vitamin C and acetylcholine coinfusion data showed that 600 mg/d allopurinol completely abolished the oxidative stress that was sensitive to high-dose vitamin C.
Conclusions— For the first time, we have shown that a steep dose–response relationship exists between allopurinol and its effect on endothelial function. We also showed that the mechanism of improvement in endothelial function with allopurinol lies in its ability to reduce vascular oxidative stress and not in urate reduction. The reduction in vascular oxidative stress was profound because high-dose allopurinol totally abolished the oxidative stress that was sensitive to the high-dose vitamin C that was used in this study.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  S. Bennett, N. Mitsides, A. Dhaygude, and A. Woywodt A pilot in distress NDT Plus, November 3, 2009; (2009) sfp159v1. [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Riches, A. F. Wright, and S. H. Ralston Recent insights into the pathogenesis of hyperuricaemia and gout Hum. Mol. Genet., October 15, 2009; 18(R2): R177 - R184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kosugi, T. Nakayama, M. Heinig, L. Zhang, Y. Yuzawa, L. G. Sanchez-Lozada, C. Roncal, R. J. Johnson, and T. Nakagawa Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice Am J Physiol Renal Physiol, August 1, 2009; 297(2): F481 - F488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Luk, G. P. Levin, E. E. Moore, X.-H. Zhou, B. R. Kestenbaum, and H. K. Choi Allopurinol and mortality in hyperuricaemic patients Rheumatology, July 1, 2009; 48(7): 804 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. George and A. Struthers The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) Trial: A Question of Dose J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2405 - 2405. [Full Text] [PDF]
|
|
|
|
 |
|
 M K Reinders, C Haagsma, T L T. A Jansen, E N van Roon, J Delsing, M A F J van de Laar, and J R B J Brouwers A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout Ann Rheum Dis, June 1, 2009; 68(6): 892 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Livesey Fructose Ingestion: Dose-Dependent Responses in Health Research J. Nutr., June 1, 2009; 139(6): 1246S - 1252S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bergamini, M. Cicoira, A. Rossi, and C. Vassanelli Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure Eur J Heart Fail, May 1, 2009; 11(5): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Navaneethan and S. Beddhu Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1260 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Forman, H. Choi, and G. C. Curhan Fructose and Vitamin C Intake Do Not Influence Risk for Developing Hypertension J. Am. Soc. Nephrol., April 1, 2009; 20(4): 863 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Forman, H. Choi, and G. C. Curhan Uric Acid and Insulin Sensitivity and Risk of Incident Hypertension Arch Intern Med, January 26, 2009; 169(2): 155 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Muir, C. Harrow, J. Dawson, K. R. Lees, C. J. Weir, N. Sattar, and M. R. Walters Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial Stroke, December 1, 2008; 39(12): 3303 - 3307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Feig, D.-H. Kang, and R. J. Johnson Uric Acid and Cardiovascular Risk N. Engl. J. Med., October 23, 2008; 359(17): 1811 - 1821. [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Feig, B. Soletsky, and R. J. Johnson Effect of Allopurinol on Blood Pressure of Adolescents With Newly Diagnosed Essential Hypertension: A Randomized Trial JAMA, August 27, 2008; 300(8): 924 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Alcaino, D. Greig, M. Chiong, H. Verdejo, R. Miranda, R. Concepcion, J. L. Vukasovic, G. Diaz-Araya, R. Mellado, L. Garcia, et al. Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure Eur J Heart Fail, July 1, 2008; 10(7): 646 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hare, B. Mangal, J. Brown, C. Fisher Jr, R. Freudenberger, W. S. Colucci, D. L. Mann, P. Liu, M. M. Givertz, R. P. Schwarz, et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2301 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.H. W. Tang The ongoing search for a stratified medicine approach in heart failure. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2310 - 2312. [Full Text] [PDF]
|
|
|
|
|
|
J. Dawson, T. J. Quinn, and M. R. Walters Response to Letter by Proctor Stroke, May 1, 2008; 39(5): e89 - e89. [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Choi and G. Curhan Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease Circulation, August 21, 2007; 116(8): 894 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Kielstein, A. Woywodt, and S. R. Salpeter Letter by Kielstein et al Regarding Article, "High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid" Circulation, May 8, 2007; 115(18): e450 - e451. [Full Text] [PDF]
|
|
|
|
|
|
J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers Response to Letter Regarding Article, "High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid" Circulation, May 8, 2007; 115(18): e451 - e451. [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Lerman and A. Lerman All Oxidase Roads Lead to Angiotensin, Too Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 703 - 704. [Full Text] [PDF]
|
|